Delivery Order SPE2DB20D7061-SPE2DB25FSPJ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,629.42 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count packages). This firm fixed-price, non-set-aside delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a contract ceiling value of $1,191.79. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Febuxostat 80 mg tablets (30-count supply) valued at $1,799.27. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery through its Corporate Office division. This award represents a single delivery order under...
- The Defense Logistics Agency awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Febuxostat 80 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.23 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was executed on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,862.32 to AmerisourceBergen Drug Corp for 30 tablets of Febuxostat 40 mg, a medication used to treat gout. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of May 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,768.65 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,292.13 and an ultimate completion date of August 27, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.16 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the companies' long-standing relationship supporting...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPJ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,672.61 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count packages) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price contract, which carries no set-aside designation, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with the Defense Logistics Agency functions as a global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for Febuxostat, a gout treatment medication, exemplifies the type of pharmaceutical commodities routinely procured through the company's federal contracts with the Defense Logistics Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/19/25 |